Published in Lancet on September 03, 1994
Polio outbreaks: a tale of torment. Lancet (1994) 3.19
Concerns about immunisation. BMJ (2000) 2.80
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
Vaccine hesitancy: an overview. Hum Vaccin Immunother (2013) 1.96
Trends in adolescent suicide: misclassification bias? Am J Public Health (2001) 1.57
Vaccine beliefs of parents who oppose compulsory vaccination. Public Health Rep (2005) 1.42
Isolation of epidemic poliovirus from sewage during the 1992-3 type 3 outbreak in The Netherlands. Epidemiol Infect (1995) 1.37
Antigenic and molecular characterization of wild type 1 poliovirus causing outbreaks of poliomyelitis in Albania and neighboring countries in 1996. J Clin Microbiol (1998) 1.14
Religious subgroups influencing vaccination coverage in the Dutch Bible belt: an ecological study. BMC Public Health (2011) 1.14
Optimal control of epidemics with limited resources. J Math Biol (2010) 1.13
How orthodox protestant parents decide on the vaccination of their children: a qualitative study. BMC Public Health (2012) 1.10
Interrupting the transmission of wild polioviruses with vaccines: immunological considerations. Bull World Health Organ (1994) 1.08
The potential impact of expanding target age groups for polio immunization campaigns. BMC Infect Dis (2014) 1.01
Surveillance of acute flaccid paralysis in Italy: 1996-1997. AFP Study Group. Acute flaccid paralysis. Eur J Epidemiol (1999) 1.00
Surveillance of acute flaccid paralysis in The Netherlands, 1992-94. Bull World Health Organ (1998) 1.00
Diphtheria antitoxin levels in the Netherlands: a population-based study. Emerg Infect Dis (1999) 0.99
An economic analysis of poliovirus risk management policy options for 2013-2052. BMC Infect Dis (2015) 0.96
Molecular characterization of a wild poliovirus type 3 epidemic in The Netherlands (1992 and 1993). J Clin Microbiol (1995) 0.94
Enhanced surveillance of acute flaccid paralysis following importation of wild poliovirus in Xinjiang Uygur Autonomous Region, China. BMC Infect Dis (2014) 0.94
Vaccination rates in a multicultural population. Arch Dis Child (2005) 0.92
Poliomyelitis in The Netherlands: a review of population immunity and exposure between the epidemics in 1978 and 1992. Epidemiol Infect (1995) 0.92
Multicenter evaluation of the Amplicor Enterovirus PCR test with cerebrospinal fluid from patients with aseptic meningitis. The European Union Concerted Action on Viral Meningitis and Encephalitis. J Clin Microbiol (1998) 0.91
Vaccine hesitancy: understanding better to address better. Isr J Health Policy Res (2016) 0.91
Vaccine refusal and the endgame: walking the last mile first. Philos Trans R Soc Lond B Biol Sci (2013) 0.89
The role of schools in the spread of mumps among unvaccinated children: a retrospective cohort study. BMC Infect Dis (2011) 0.83
Molecular detection of an importation of type 3 wild poliovirus into Canada from The Netherlands in 1993. Appl Environ Microbiol (1997) 0.83
How healthcare professionals respond to parents with religious objections to vaccination: a qualitative study. BMC Health Serv Res (2012) 0.81
A new paradigm for international disease control: lessons learned from polio eradication in Southeast Asia. Am J Public Health (2001) 0.81
The District Immunisation Coordinator. Arch Dis Child (2000) 0.80
Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure. Clin Diagn Lab Immunol (2000) 0.80
The role of religious leaders in promoting acceptance of vaccination within a minority group: a qualitative study. BMC Public Health (2013) 0.78
Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response. Public Health Rep (2012) 0.78
Phylogeny of imported and reestablished wild polioviruses in theDemocratic Republic of the Congo from 2006 to 2011. J Infect Dis (2014) 0.77
An outbreak following importation of wild poliovirus in Xinjiang Uyghur Autonomous Region, China, 2011. BMC Infect Dis (2015) 0.75
Antipoliomyelitis neutralizing antibodies in maternal and neonatal serum. Eur J Epidemiol (1997) 0.75
Certifying the elimination of poliomyelitis from Europe: advancing towards global eradication. Eur J Epidemiol (1998) 0.75
Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J Clin Microbiol (2001) 6.40
Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet (2004) 4.39
Development and clinical evaluation of a polymerase chain reaction test for detection of Chlamydia trachomatis. J Clin Microbiol (1992) 3.01
Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults. J Clin Microbiol (2003) 2.59
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis (1997) 2.32
White matter damage in neonatal enterovirus meningoencephalitis. Neurology (2006) 2.32
Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis (2000) 2.29
Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J (2007) 2.27
Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol (1996) 2.23
Genetic analysis of wild-type poliovirus importation into The Netherlands (1979-1995). J Infect Dis (1997) 2.13
No epidemiological evidence for infant vaccinations to cause allergic disease. Vaccine (2004) 2.13
Enzyme-linked immunosorbent assay for measurement of antibody against cytomegalovirus and rubella virus in a single serum dilution. J Clin Pathol (1981) 1.91
The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis. J Neurol Neurosurg Psychiatry (1996) 1.87
Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol (1995) 1.83
Direct enzyme-linked immunosorbent assay that uses peroxidase-labeled antigen for determination of immunoglobulin M antibody to cytomegalovirus. J Clin Microbiol (1981) 1.73
Pneumococcal vaccines: an update on current strategies. Vaccine (2004) 1.69
Comparison of the polymerase region of small round structured virus strains previously classified in three antigenic types by solid-phase immune electron microscopy. Arch Virol (1994) 1.68
Australia's last reported case of wild poliovirus infection. Commun Dis Intell (1999) 1.63
Enzyme-linked immunosorbent assay that uses labeled antigen for detection of immunoglobulin M and A antibodies in toxoplasmosis: comparison with indirect immunofluorescence and double-sandwich enzyme-linked immunosorbent assay. J Clin Microbiol (1983) 1.59
Interlaboratory evaluation of indirect enzyme-linked immunosorbent assay, antibody capture enzyme-linked immunosorbent assay, and immunoblotting for detection of immunoglobulin M antibodies to Toxoplasma gondii. J Clin Microbiol (1987) 1.55
Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine (1996) 1.54
The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect (2000) 1.48
Comparison of two panels of monoclonal antibodies for determination of Chlamydia trachomatis serovars. J Clin Microbiol (1994) 1.48
Enzyme-linked immunosorbent assay for quantitation of toxoplasma antibodies in human sera. J Clin Pathol (1980) 1.47
Detection of HIV antibodies in saliva as a tool for epidemiological studies. AIDS (1992) 1.42
Rate of recurrent collapse after vaccination with whole cell pertussis vaccine: follow up study. BMJ (1998) 1.40
[Vertical HIV-I-transmission. I. Risk and prevention in pregnancy]. Ned Tijdschr Geneeskd (1998) 1.40
[Osteomyelitis as a complication following BCG vaccination]. Ned Tijdschr Geneeskd (1995) 1.39
[The diphtheria epidemic in the Russian Federation and recommendations concerning diphtheria vaccination in The Netherlands]. Ned Tijdschr Geneeskd (1994) 1.39
[Chickenpox in pregnancy with serious consequences for both mother and child]. Ned Tijdschr Geneeskd (2003) 1.39
Subclinical Legionella infection in workers near the source of a large outbreak of Legionnaires disease. J Infect Dis (2001) 1.39
[A measles epidemic in an adequately vaccinated middle school population]. Ned Tijdschr Geneeskd (1994) 1.39
Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. Br J Haematol (2001) 1.38
[Causative role of infections with viruses or atypical pathogens in acute exacerbations of chronic bronchitis less frequent than expected]. Ned Tijdschr Geneeskd (1996) 1.38
[Immune response following preventive intracutaneous rabies vaccination]. Ned Tijdschr Geneeskd (1991) 1.38
[Current polio infections in The Netherlands]. Ned Tijdschr Geneeskd (1992) 1.38
Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage. Vaccine (1999) 1.38
Isolation of epidemic poliovirus from sewage during the 1992-3 type 3 outbreak in The Netherlands. Epidemiol Infect (1995) 1.37
Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiol Infect (1998) 1.34
Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice. Br J Gen Pract (2001) 1.33
Measles outbreak in a community with very low vaccine coverage, the Netherlands. Emerg Infect Dis (2001) 1.33
Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age. Vaccine (2000) 1.31
Detection, typing, and subtyping of enteric adenoviruses 40 and 41 from fecal samples and observation of changing incidences of infections with these types and subtypes. J Clin Microbiol (1993) 1.31
Antigenic and genetic characterization of swine influenza A (H1N1) viruses isolated from pneumonia patients in The Netherlands. Virology (2001) 1.30
[Increase in preventive screening: need for revision of the Dutch 'Wet op het Bevolkingsonderzoek' (Population Screening Act)]. Ned Tijdschr Geneeskd (2008) 1.29
Continued seasonal circulation of enterovirus D68 in the Netherlands, 2011-2014. Euro Surveill (2014) 1.28
Performance of different mono- and multiplex nucleic acid amplification tests on a multipathogen external quality assessment panel. J Clin Microbiol (2011) 1.27
Initiation signals for complementary strand DNA synthesis on single-stranded plasmid DNA. Nucleic Acids Res (1983) 1.26
European proficiency testing program for molecular detection and quantitation of hepatitis B virus DNA. J Clin Microbiol (2001) 1.24
Hemadsorption immunosorbent technique for determination of rubella immunoglobulin M antibody. J Clin Microbiol (1981) 1.24
Multicenter quality assessment of PCR methods for detection of enteroviruses. J Clin Microbiol (1999) 1.23
Standardization of poliovirus neutralizing antibody tests. Rev Infect Dis (1984) 1.23
Molecular epidemiology of echovirus 30 in Europe: succession of dominant sublineages within a single major genotype. Arch Virol (2001) 1.23
High prevalence of nasal MRSA carriage in slaughterhouse workers in contact with live pigs in The Netherlands. Epidemiol Infect (2010) 1.18
Molecular epidemiology of wild poliovirus type 1 in Europe, the Middle East, and the Indian subcontinent. J Infect Dis (1995) 1.18
Use of the enzyme-linked immunosorbent assay for the early diagnosis of Mycoplasma pneumoniae infection. Eur J Clin Microbiol (1984) 1.14
Phylogenetic analysis of new hepatitis B virus isolates from Nigeria supports endemicity of genotype E in West Africa. J Med Virol (2001) 1.14
Antigenic and molecular characterization of wild type 1 poliovirus causing outbreaks of poliomyelitis in Albania and neighboring countries in 1996. J Clin Microbiol (1998) 1.14
Quantitation of immunoglobulin E antibody to cytomegalovirus by antibody capture enzyme-linked immunosorbent assay. J Clin Microbiol (1985) 1.12
Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis (1995) 1.11
Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients. Bone Marrow Transplant (2000) 1.09
The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: a nationwide prospective study. J Infect Dis (2000) 1.09
HIV-1 drug resistance genotyping quality assessment: results of the ENVA7 Genotyping Proficiency Programme. J Clin Virol (2008) 1.08
Enzyme immunoassay with enhanced specificity for detection of antibodies to Chlamydia trachomatis. J Clin Microbiol (1994) 1.08
Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992-1993. Am J Epidemiol (1996) 1.07
Enterovirus infections of the central nervous system. Intervirology (1997) 1.06
A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1. J Gen Virol (1999) 1.05
Symptoms of influenza virus infection in hospitalized patients. Infect Control Hosp Epidemiol (2008) 1.05
Late onset polio sequelae: disabilities and handicaps in a population-based cohort of the 1956 poliomyelitis outbreak in The Netherlands. Arch Phys Med Rehabil (1999) 1.04
Detection of amplified Chlamydia trachomatis DNA using a microtiter plate-based enzyme immunoassay. Eur J Clin Microbiol Infect Dis (1994) 1.03
[Whooping cough in The Netherlands, 1989-1994]. Ned Tijdschr Geneeskd (1995) 1.03
Multicentre quality control study for detection of Mycobacterium tuberculosis in clinical samples by nucleic amplification methods. Clin Microbiol Infect (2004) 1.02
Immunoglobulin production in human mixed lymphocyte cultures: implications for co-cultures of cells from patients and healthy donors. J Immunol (1982) 1.02
Post-transfusion non-A, non-B hepatitis in the Netherlands. Br Med J (Clin Res Ed) (1981) 1.02
Prevalence of antibodies against rubella virus in The Netherlands 9 years after changing from selective to mass vaccination. Epidemiol Infect (1999) 1.02
Active Epstein-Barr virus infection after allogeneic stem cell transplantation: re-infection or reactivation? Transpl Infect Dis (2005) 1.01
Surveillance of acute flaccid paralysis in The Netherlands, 1992-94. Bull World Health Organ (1998) 1.00
Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors. Environ Health Perspect (2001) 1.00
Diphtheria antitoxin levels in the Netherlands: a population-based study. Emerg Infect Dis (1999) 0.99
Poliovirus circulation among schoolchildren during the early phase of the 1992-1993 poliomyelitis outbreak in The Netherlands. J Infect Dis (2001) 0.99
Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis. Eur J Clin Microbiol Infect Dis (1992) 0.99
Poliovirus-induced suppression of lymphocyte stimulation: a macrophage-mediated effect. Immunology (1979) 0.99
Production and potential use of monoclonal antibodies against polio viruses. Dev Biol Stand (1981) 0.98
New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines. Dev Biol Stand (1978) 0.98
Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation. Blood (1994) 0.96